Xeljanz XR and Malignancies
Result of checking the interaction of drug Xeljanz XR and disease Malignancies for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Malignancies, including lymphomas, have been reported with the use of tofacitinib. Before starting therapy with this agent, the prescriber should balance the benefits against the risks of therapy in patients with a known malignancy other than a successfully treated non-melanoma skin cancer, or when considering continuing therapy in patients who develop a malignancy. Periodic examination is recommended for patients who are at increased risk for cancer.
Generic Name: tofacitinib
Brand Name: Xeljanz, Xeljanz XR
Synonyms: n.a.